Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Buy
55
BN Quote, Financials, Valuation and Earnings
Last price:
$51.68
Seasonality move
:
4.66%
Day range:
$52.49 - $54.40
52-week range:
$38.18 - $62.78
Dividend yield:
0.61%
P/E ratio:
180.87x
P/S ratio:
1.00x
P/B ratio:
1.96x
Volume:
2.5M
Avg. volume:
3.3M
1-year change:
34.4%
Market cap:
$81.9B
Revenue:
$86B
EPS (TTM):
$0.30
Analysts' Opinion
-
Consensus RatingBrookfield has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $66.75, Brookfield has an estimated upside of 22.75% from its current price of $54.38.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $41.00 representing 24.61% downside risk from its current price of $54.38.
Fair Value
-
According to the consensus of 4 analysts, Brookfield has 22.75% upside to fair value with a price target of $66.75 per share.
BN vs. S&P 500
-
Over the past 5 trading days, Brookfield has underperformed the S&P 500 by -1.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Brookfield does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Brookfield revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Brookfield reported revenues of $19.4B.
Earnings Growth
-
Brookfield earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Brookfield reported earnings per share of $0.25.
Enterprise value:
420B
EV / Invested capital:
--
Price / LTM sales:
1.00x
EV / EBIT:
21.60x
EV / Revenue:
4.88x
PEG ratio (5yr expected):
0.16x
EV / Free cash flow:
-116.58x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
14.39x
Gross Profit (TTM):
$18.1B
Return On Assets:
0.13%
Net Income Margin (TTM):
0.75%
Return On Equity:
0.38%
Return On Invested Capital:
0.16%
Operating Margin:
25.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $92.8B | $95.9B | $86B | $24.5B | $19.4B | |
| Gross Profit | $14.3B | $14.5B | $18.1B | $3.9B | $5B | |
| Operating Income | $14.1B | $14.4B | $18B | $3.9B | $5B | |
| EBITDA | $25B | $30.7B | $29.2B | $9.7B | $6.8B | |
| Diluted EPS | $1.16 | $0.62 | $0.30 | $0.42 | $0.25 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $41.9B | $56.3B | $53.4B | $46.7B | $56.2B | |
| Total Assets | $343.7B | $391B | $441.3B | $490.1B | $490.4B | |
| Current Liabilities | $49.5B | $65.1B | $77.7B | $91.1B | $86.1B | |
| Total Liabilities | $221.1B | $256.3B | $299.4B | $321.9B | $325B | |
| Total Equity | $122.6B | $134.7B | $141.9B | $168.2B | $165.4B | |
| Total Debt | $148.4B | $175.9B | $214.1B | $233.7B | $234.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $8.8B | $6.5B | $7.6B | $1.5B | $3.2B | |
| Cash From Investing | -$39.7B | -$29.8B | -$30B | -$5.7B | -$9.4B | |
| Cash From Financing | $32.5B | $19.9B | $26.9B | $3.1B | $9.8B | |
| Free Cash Flow | $1.5B | -$1.6B | -$3.6B | -$1.2B | $4M | |
BN
Sector
Market Cap
$81.9B
$622M
Price % of 52-Week High
86.62%
86%
Dividend Yield
0.61%
1.98%
Shareholder Yield
-0.21%
3.69%
1-Year Price Total Return
34.4%
9.44%
Beta (5-Year)
1.595
0.555
Dividend yield:
0.61%
Annualized payout:
$0.32
Payout ratio:
103.43%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$53.95
200-day SMA
Buy
Level
$52.84
Bollinger Bands (100)
Sell
Level
54.29 - 60.25
Chaikin Money Flow
Buy
Level
896.2M
20-day SMA
Buy
Level
$52.56
Relative Strength Index (RSI14)
Buy
Level
50.77
ADX Line
Sell
Level
21.13
Williams %R
Neutral
Level
-20.1429
50-day SMA
Sell
Level
$56.48
MACD (12, 26)
Sell
Level
-0.59
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
837.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.449)
Sell
CA Score
(Annual)
Level (-2.0841)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.3498)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has three businesses Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity, Real Estate and Corporate Activities. it invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. It generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, Colombia, Germany, Other Europe, Other Asia, and other countries.
Stock Forecast FAQ
In the current month, BN has received 2 Buy ratings 1 Hold ratings, and 1 Sell ratings. The BN average analyst price target in the past 3 months is $66.75.
-
Where Will Brookfield Stock Be In 1 Year?
According to analysts, the consensus estimate is that Brookfield share price will rise to $66.75 per share over the next 12 months.
-
What Do Analysts Say About Brookfield?
Analysts are divided on their view about Brookfield share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Brookfield is a Sell and believe this share price will drop from its current level to $41.00.
-
What Is Brookfield's Price Target?
The price target for Brookfield over the next 1-year time period is forecast to be $66.75 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is BN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Brookfield is a Buy. 2 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of BN?
You can purchase shares of Brookfield via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Brookfield shares.
-
What Is The Brookfield Share Price Today?
Brookfield was last trading at $51.68 per share. This represents the most recent stock quote for Brookfield. Yesterday, Brookfield closed at $54.38 per share.
-
How To Buy Brookfield Stock Online?
In order to purchase Brookfield stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 11.11% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 10.53% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 6.15% over the past day.
